Scott Frankenthaler
Managing Consultant

Scott has more than seven years of experience in biotech and life science consulting, with a focus on new product planning, business development, and asset commercialization. Prior to joining Bluestar he was Manager of Corporate Development and Strategy at GRO Biosciences, an immunology-focused synthetic biology biotechnology company. Scott also worked as Manager of Business Development at Syros Pharmaceuticals where he led the partnering efforts for several preclinical and clinical assets. Additionally, he gained his consulting experience at Putnam Associates and Artisan Healthcare Consulting, where he led or conducted 50+ projects in new product planning, portfolio optimization, clinical strategy, commercialization, market access, pricing, business development, and due diligence. Scott has therapeutic area expertise and experience in immunology, rare and metabolic diseases, as well as oncology. Scott holds a BA from Johns Hopkins University in Public Health.